Cancer Immunotherapy Drugs Driving End-of-Life Cost Increases

Immunotherapy drugs accounted for 84% of the overall increase in Medicare Part B spending for end-of-life outpatient cancer care.
Medscape Medical News

source https://www.medscape.com/viewarticle/989010?src=rss

Comments

Popular posts from this blog

DC’s Harllee Harper Is Using Public Health Tools to Prevent Gun Violence. Will It Work?